Is the business good?
How good a business is COO?
Cooper Companies (The) earns 3.5% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
3.5%
Return on invested capital · cost of capital 9.0% · 5.5 points below what the capital costs: growth destroys value
- Operating margin
- 12%
Operating margin · Medical Instruments & Supplies median 5.8% · 12 months to Q2 2026
- Cash conversion
- 2.42×
Cash conversion · 0.88× a year ago · every dollar of reported profit arrived as cash, and more
- Share count, year on year
- −2.8%
Share count, year on year · bought back, each share owns more of the company
| Year | Operating margin |
|---|---|
| FY2020 | 13% |
| FY2021 | 17% |
| FY2022 | 15% |
| FY2023 | 15% |
| FY2024 | 18% |
| FY2025 | 17% |
Details›
- Gross margin12 months to Q2 2026
- 66%
- Operating margin12 months to Q2 2026
- 12%
- Net margin12 months to Q2 2026
- 5.6%
- Free cash flow margin
- 13%
- R&D as % of revenue
- 4.1%
- Revenue, trailing twelve months
- $4.23B
- Free cash flow, trailing twelve months
- $570M
- Net income, trailing twelve months
- $236M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 3.5%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.
Medical Instruments & Supplies
Ranks #19 of 27 by Smart Score